SOPHIA’S BENLYSTA TREATMENT

Hypothetical patient profile. May not be
representative of all patients.

  • TRANSCRIPT

    CHARLOTTE: When her doctor suggested adding BENLYSTA, we were just really hopeful it would make a difference and help her get back to being a kid again.

    ON-SCREEN TEXT: Sophia*

    ON-SCREEN TEXT: Results may vary.

    ON-SCREEN TEXT: : * Hypothetical patient profile. May not be representative of all BENLYSTA patients.

    CHARLOTTE: She’s been taking BENLYSTA infusions for about 10 months now and I think it is making a difference. Her rash has cleared up and she’s having far fewer bad days keeping her from activities.

    SOPHIA: At first, I didn’t want infusions because I was really scared of needles. But it’s ok now. My mom and the nurses hold my hand and then I close my eyes, and the needle part is over pretty fast.

    ON-SCREEN TEXT: Sophia’s BENLYSTA IV dosing: 10 mg/kg every 2 weeks for the first 3 infusions and every 4 weeks thereafter.

    ON-SCREEN TEXT: Results may vary.

    CHARLOTTE: As Sophia's symptoms improved, our entire family has felt the difference. We hadn’t really realized how much we were avoiding places and events out of fear that Sophia would wake up not feeling well.

    SOPHIA: I’m seeing my friends way more these days – even having sleepovers on weekends. And I know my mom worries less now, so that makes me happy!

    ON-SCREEN TEXT: Trademarks owned or licensed by GSK. BELVID210029 September 2021.

You may also like

SEE SOPHIA’S DIAGNOSIS STORY
REVIEW SOPHIA’S
INITIAL TREATMENT

Hypothetical patient profile. May not be
representative of all patients.